The launch of the Retatru vial marks a notable shift in the landscape to weight management . This novel therapy combines two mechanisms – stimulation of the GLP-1 target and reduction of the DPP-4 process – suggesting a distinctive strategy for tackling weight concerns. Early research data demonstrate substantial efficacy in assisting considera